HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
In the SUSTAIN clinical trial program evaluating subcutaneous semaglutide for type 2 diabetes, once-weekly dosing (0.5 mg or 1.0 mg) reduced HbA1c by 1.5% to 1.8% from baseline, with superior glycemic control compared to specific comparators in head-to-head trials (SUSTAIN-7 vs dulaglutide
Other studies have successfully used ethyl chloroacetoacetate as a starting material to produce ethyl (R)-4-chloro-3-hydroxybutyrate with high optical purity via asymmetric catalytic hydrogenation, which is then converted into L-carnitine
Skin diseases are not only troublesome for the proper functioning of the body, but their unsightly appearance also lowers our well-being, which is why appropriate therapy to help cure or alleviate symptoms is so important
BA: Formal analysis, Software, Visualization, Writing original draft, Writing review & editing
Suppresses appetite (central action): Reduces hunger signals in the brain, leading to decreased food intake and weight loss 1,2
